Evidence map›Paper›PMID 28752410›Full record

Trial reportTranslational stroke research2017

Infections Up to 76 Days After Stroke Increase Disability and Death.

Annastazia E Learoyd, Lisa Woodhouse, Laurence Shaw, Nikola Sprigg, Daniel Bereczki, Eivind Berge, Valeria Caso, Hanne Christensen, Ronan Collins, Anna Czlonkowska and 13 more

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Translational stroke research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00989716 (A Prospective, Collaborative, International, Multicentre, Randomised, Parallel-group, Single and Outcome Blinded, Controlled, Factorial Trial to Investigate the Safety and Efficacy of Treatment With Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, and of Continuing or Stopping Temporarily Pre-stroke Antihypertensive Therapy, in Patients With Acute Stroke), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00989716 phase3unknown statusnot on this map

A Prospective, Collaborative, International, Multicentre, Randomised, Parallel-group, Single and Outcome Blinded, Controlled, Factorial Trial to Investigate the Safety and Efficacy of Treatment With Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, and of Continuing or Stopping Temporarily Pre-stroke Antihypertensive Therapy, in Patients With Acute Stroke

TypeinterventionalSponsorUniversity of NottinghamRan2001 to 2013Enrolled3,500ConditionsStrokeArmsTransdermal glyceryl trinitrate patch, Pre-stroke antihypertensives
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. State of the science in inflammation and stroke recovery: A systematic review.Annals of physical and rehabilitation medicine · 2022
    Pooled it
  2. Models Containing the Braden Scale Predict Activities of Daily Living Improvement in Post-Stroke Hemiplegia: A Single Center Retrospective Cohort Study.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 13 countries.

Annastazia E LearoydSchool of Life Sciences, University of Nottingham, Nottingham, UK.
Lisa WoodhouseStroke Trials Unit Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Laurence ShawSchool of Mathematical Sciences, University of Nottingham, Nottingham, UK.
Nikola SpriggStroke Trials Unit Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Daniel BereczkiDepartment of Neurology, Semmelweis University, Budapest, Hungary.
Eivind BergeDepartment of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Valeria CasoStroke Unit, Santa Maria Hospital, University of Perugia, Perugia, Italy.
Hanne ChristensenDepartment of Neurology, Bispebjerg Hospital, Copenhagen, Denmark.
Ronan CollinsStroke Service, Adelaide and Meath Hospital, Tallaght, Ireland.
Anna Czlonkowska2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
Anwar El EtribiAinshams University, 7 Ahram Street, Heliopolis, Cairo, Egypt.
Tracy D FarrSchool of Life Sciences, University of Nottingham, Nottingham, UK.
John GommansDepartment of Medicine, Hawke's Bay Hospital, Hastings, New Zealand.
Ann-Charlotte LaskaDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
George NtaiosDepartment of Medicine, University of Thessaly, Larissa, Greece.
Serefnur OzturkDepartment of Neurology, Selcuk University Medical Faculty, Konya, Turkey.
Stuart J PocockDepartment of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Kameshwar PrasadDepartment of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Joanna M WardlawDivision of Neuroimaging Sciences, Centre for Clinical Brain Sciences, Western General Hospital, Edinburgh, UK.
Kevin C FoneSchool of Life Sciences, University of Nottingham, Nottingham, UK.
Philip M BathStroke Trials Unit Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Rebecca C TruemanSchool of Life Sciences, University of Nottingham, Nottingham, UK. Rebecca.Trueman@nottingham.ac.uk.
ENOS Trial investigators
University of Nottingham · GBSelçuk University · TRSemmelweis University · HUBispebjerg Hospital · DKHeliopolis University · EGKarolinska Institutet · SELondon School of Hygiene & Tropical Medicine · GBOslo University Hospital · NOTallaght University Hospital · IEUniversity of Perugia · ITUniversity of Thessaly · GRWestern General Hospital · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F016956/1Department of Health 11/129/109Medical Research Council G0501797
6 · The paper itself

Abstract

Early infection after stroke is associated with a poor outcome. We aimed to determine whether delayed infections (up to 76 days post-stroke) are associated with poor outcome at 90 days. Data came from the international Efficacy of Nitric Oxide Stroke (ENOS, ISRCTN99414122) trial. Post hoc data on infections were obtained from serious adverse events reports between 1 and 76 days following stroke in this large cohort of patients. Regression models accounting for baseline covariates were used to analyse fatalities and functional outcomes (modified Rankin Scale (mRS), Barthel Index, Euro-Qol-5D) at 90 days, in patients with infection compared to those without infection. Of 4011 patients, 242 (6.0%) developed one or more serious infections. Infections were associated with an increased risk of death (p < 0.001) and an increased likelihood of dependency (measured by mRS) compared to those of all other patients (p < 0.001). This remained when only surviving patients were analysed, indicating that the worsening of functional outcome is not due to mortality (p < 0.001). In addition, the timing of the infection after stroke did not alter its detrimental association with fatality (p = 0.14) or functional outcome (p = 0.47). In conclusion, severe post-stroke infections, whether occurring early or late after stroke, are associated with an increased risk of death and poorer functional outcome, independent of differences in baseline characteristics or treatment. Not only are strategies needed for reducing the risk of infection immediately after stroke, but also during the first 3 months following a stroke. This study is registered: ISRCTN registry, number ISRCTN99414122, ClinicalTrials.gov Identifier, NCT00989716.

Indexed as

AdultAgedAged, 80 and overFemaleHumansIncidenceInfectionsMaleMiddle AgedNitroglycerinRecovery of FunctionRetrospective StudiesStrokeTime FactorsTransdermal PatchVasodilator AgentsNitroglycerinVasodilator AgentsDisabilityGlyceryl trinitrateInfectionStroke

Identifiers

PMID28752410
PMCPMC5818141
OpenAlexW2741758712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.